Laddar...
Anti‐PD‐L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma
Immunotherapy based on blockade of the programmed death‐1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) axis has shown promising clinical activity for renal cell carcinoma (RCC) patients; however, the most effective use of these agents in combination with conventional targeted therapy remains to be resol...
Sparad:
| I publikationen: | Cancer Sci |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5198964/ https://ncbi.nlm.nih.gov/pubmed/27712020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13099 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|